ÂÜÀòÂÒÂ×

The Board of Directors at Immix Biopharma oversees corporate governance, strategic direction, and financial stewardship to ensure the company's advancements in Tissue-Specific Therapeutics (TSTx)â„¢ align with its goals in oncology and inflammation. They provide executive oversight, monitor performance, and make pivotal decisions to guide the clinical-stage biopharmaceutical company toward sustainable growth and innovation.